Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.44 |
| ▸ | ATR | Q13535 | 2/20 | 0.41 |
| ▸ | ATRIP | Q8WXE1 | 2/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 3/20 | 0.39 |
| ▸ | KMO | O15229 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.37 |
| ▸ | COMT | P21964 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863097 | 0.90 | COMT (0.41) | IDO1NOTUMCOMTALDH1A1 | |
| SCHEMBL863096 | 0.82 | COMT (0.49) | NOTUMCOMTALDH1A1 | |
| SCHEMBL20411750 | 0.81 | ALPL (0.41) | ALPLKMOALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL863311 | 0.78 | TGFBR1 (0.39) | IDO1ALPLKMOALDH1A1CYP1A2 | |
| SCHEMBL16404995 | 0.76 | ALPL (0.38) | ALPLKMOALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17071783 | 0.72 | IDO1 (0.62) | IDO1NOTUMHCRTR1HCRTR2ADRA1A | |
| SCHEMBL18287250 | 0.71 | KMO (0.47) | ALPLKMOP2RX7CYP3A4F2RL3 | |
| SCHEMBL30442505 | 0.69 | IDO1 (0.67) | IDO1NOTUMADRA1ACOMTALDH1A1 | |
| SCHEMBL503953 | 0.69 | CCR1 (0.55) | HCRTR1HCRTR2ALPLKMOALDH1A1 | |
| SCHEMBL29766750 | 0.69 | CCR1 (0.55) | HCRTR1HCRTR2ALPLKMOALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507679-B2 | Heteroleptic, dual tridentate Ru(II) complexes as sensitizers for dye-sensitized solar cells | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-08-13 | — | — | US | disclosed |
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | RUVBL2, RUVBL1, CCNL2 | IDO1 1449/4885NOTUM 3748/4885ATR 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.